QA: Johnson Johnson in us_pharma/2012

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000200406_2013_Johnson_Johnson.pdf

Logs

Graph

Absolute values for 0000200406, Johnson Johnson

  xvar xval
0 AssetsCurrent 46,116,000,000
1 IntangibleAssetsNetIncludingGoodwill 51,176,000,000
2 PropertyPlantAndEquipmentNet 16,097,000,000
3 remainder_Assets 7,958,000,000
4 LiabilitiesCurrent 24,262,000,000
5 LiabilitiesNoncurrent 20,041,000,000
6 remainder_Liabilities 12,218,000,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 20,869,000,000
9 ResearchAndDevelopmentExpense 7,665,000,000
10 remainder_Expenses 26,614,000,000
11 remainder_Revenues 67,224,000,000
12 remainder_NetIncome -1,562,000,000
13 remainder_ComprehensiveNetIncome 161,000,000
  yvar yval
0 Assets 121,347,000,000
1 Liabilities 56,521,000,000
2 Expenses 55,148,000,000
3 Revenues 67,224,000,000
4 StockholdersEquity 64,826,000,000
5 NetIncome 10,514,000,000
6 ComprehensiveNetIncome 10,594,500,000
7 BaseVar 150,981,500,000
8 EconomicCapitalRatiobeforeLimitedLiability 1.71
9 EconomicCapitalRatio 2.83

Edgar->Model Mapping

Feature Distribution

Change over Time